Utility Values in Colorectal Cancer Patients Treated with Chemotherapy

被引:4
作者
Atfannezhad, Majid [1 ]
Sharifi, Mehran [2 ]
Madadizadeh, Farzan [3 ,4 ]
Ameri, Hosein [5 ]
机构
[1] Shahid Sadoughi Univ Med Sci, Dept Hlth Technol Assessment, Yazd, Iran
[2] Isfahan Univ Med Sci, Canc Prevent Res Ctr, Esfahan, Iran
[3] Shahid Sadoughi Univ Med Sci, Ctr Healthcare Data Modeling, Sch Publ Hlth, Dept Biostat, Yazd, Iran
[4] Shahid Sadoughi Univ Med Sci, Ctr Healthcare Data Modeling, Sch Publ Hlth, Dept Epidemiol, Yazd, Iran
[5] Shahid Sadoughi Univ Med Sci, Hlth Policy & Management Res Ctr, Sch Publ Hlth, Dept Hlth Serv Management, Yazd, Iran
关键词
Colorectal; utility; EQ-5D-5L; cTTO; QUALITY-OF-LIFE; SURVIVORS; ASSOCIATION; PREDICTORS; VARIABLES; SUPPORT; EUROQOL;
D O I
10.1080/07357907.2021.1992632
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Calculating utility values in colorectal cancer (CRC) patients under chemotherapy treatment is important for studies of economic evaluations. The EQ-5D-5L and composite time trade-off (cTTO) were used to calculate utility values in 105 patients with CRC in Iran. The mean EQ-5D-5L index and cTTO values were 0.45 +/- 0.03 and 0.51 +/- 0.02, respectively. Anxiety and pain were the most common problems reported by the patients. The BetaMix showed that lower mean utility values were significantly associated with females, aging, a low level of income, a greater number of comorbidities, and an advanced stage of cancer.
引用
收藏
页码:46 / 54
页数:9
相关论文
共 31 条
[1]  
Ameri Hosein, 2020, Med J Islam Repub Iran, V34, P121, DOI 10.34171/mjiri.34.121
[2]   Candidate Predictors of Health-Related Quality of Life of Colorectal Cancer Survivors: A Systematic Review [J].
Bours, Martijn J. L. ;
van der Linden, Bernadette W. A. ;
Winkels, Renate M. ;
van Duijnhoven, Franzel J. ;
Mols, Floortje ;
van Roekel, Eline H. ;
Kampman, Ellen ;
Beijer, Sandra ;
Weijenberg, Matty P. .
ONCOLOGIST, 2016, 21 (04) :433-452
[3]   A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D [J].
Buchholz, Ines ;
Janssen, Mathieu F. ;
Kohlmann, Thomas ;
Feng, You-Shan .
PHARMACOECONOMICS, 2018, 36 (06) :645-661
[4]   A History of Cancer Chemotherapy [J].
DeVita, Vincent T., Jr. ;
Chu, Edward .
CANCER RESEARCH, 2008, 68 (21) :8643-8653
[5]   Health-related quality of life in colorectal cancer [J].
Farkkila, N. ;
Sintonen, H. ;
Saarto, T. ;
Jarvinen, H. ;
Hanninen, J. ;
Taari, K. ;
Roine, R. P. .
COLORECTAL DISEASE, 2013, 15 (05) :E215-E222
[6]  
Fried LP, 2004, J GERONTOL A-BIOL, V59, P255
[7]   Association of social support, functional status, and psychological variables with changes in health-related quality of life outcomes in patients with colorectal cancer [J].
Gonzalez-Saenz de Tejada, M. ;
Bilbao, A. ;
Bare, M. ;
Briones, E. ;
Sarasqueta, C. ;
Quintana, J. M. ;
Escobar, A. .
PSYCHO-ONCOLOGY, 2016, 25 (08) :891-897
[8]   Long-term quality of life of postoperative rectal cancer patients [J].
Hamashima, C .
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2002, 17 (05) :571-576
[9]   Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L) [J].
Herdman, M. ;
Gudex, C. ;
Lloyd, A. ;
Janssen, M. F. ;
Kind, P. ;
Parkin, D. ;
Bonsel, G. ;
Badia, X. .
QUALITY OF LIFE RESEARCH, 2011, 20 (10) :1727-1736
[10]   Literature Review and Practical Aspects on the Management of Oxaliplatin-Associated Toxicity [J].
Hoff, Paulo M. ;
Saad, Everardo D. ;
Costa, Frederico ;
Coutinho, Anelisa K. ;
Caponero, Ricardo ;
Prolla, Gabriel ;
Gansl, Rene C. .
CLINICAL COLORECTAL CANCER, 2012, 11 (02) :93-100